A randomized, blind, dose-escalation, multiple-dose Phase I clinical study to evaluate the safety, tolerability, and pharmacokinetics of NVS451 fusion protein for injection in Chinese patients with moderate-to-severe plaque psoriasis
Phase Ia clinical trial evaluating the safety, tolerability and pharmacokinetics of NVS451 fusion protein for injection in healthy subjects in a single-center, randomized, double-blind, placebo-controlled, single-dose escalation